Literature DB >> 22173721

Association of the -33C/G OSF-2 and the 140A/G LF gene polymorphisms with the risk of chronic rhinosinusitis with nasal polyps in a Polish population.

Hanna Zielinska-Blizniewska1, Przemyslaw Sitarek, Jaroslaw Milonski, Lukasz Dziki, Karolina Przybylowska, Jurek Olszewski, Ireneusz Majsterek.   

Abstract

Nasal polyps are strongly associated with a risk of chronic rhinosinusitis development as well as other obstruction including asthma and allergy. The following study tested the association of the 140A/G polymorphism of lactoferine (LF) encoding gene and the -33C/G polymorphism of osteoblast-specific factor-2 (OSF-2) encoding gene with a risk of chronic rhinosinusitis with nasal polyps in a Polish population. One hundred ninety five patients of chronic rhinosinusitis with nasal polyps as well as 200 sex, age and ethnicity matched control subjects without chronic sinusitis and nasal polyps were enrolled in this study. Among the group of patients 63 subjects were diagnosed with allergy and 65 subjects with asthma, respectively. DNA was isolated from peripheral blood lymphocytes of patients as well as controls and gene polymorphisms were analyzed by restriction fragments length polymorphism polymerase chain reaction (RFLP-PCR). We reported that the 140A/G LF (OR 4.78; 95% CI 3.07-7.24), the -33C/G OSF-2 OR 3.48; 95% CI 2.19-5.52) and the -33G/G OSF-2 (OR 16.45; 95% CI 6.71-40.30) genotypes were associated with an increased risk of chronic rhinosinusitis with nasal polyps among analyzed group of patients. Moreover, the group of patients without allergy or asthma indicated the association of the -33C/G (OR 3.72; 95% CI 2.24-6.19 and OR 15.11; 95% CI 5.91-38.6) and -33G/G (OR 3.73; 95% CI 2.24-6.19 and OR 14.07; 95% CI 5.47-36.16) genotypes of the OSF-2 as wells as 140A/G (OR 3.89; 95% CI 2.40-6.31 and OR 3.62; 95% CI 2.45-5.34) genotype of OSF-2 with an increased risk of chronic rhinosinusitis with nasal polyps. Finally, it was also found that the selected group of patients with allergy or asthma indicated a very strong association of the -33C/G (OR 2.40; 95% CI 1.23-4.69 and OR 2.40; 95% CI 1.23-4.69, respectively) and -33G/G (OR 16.01; 95% CI 5.77-44.41 and OR 17.90; 95% CI 6.53-49.05, respectively) genotypes of the OSF-2 as wells as 140A/G (OR 3.22; 95% CI 1.74-6.11 and OR 3.25; 95% CI 1.75-6.04, respectively) genotypes with an increased risk of chronic rhinosinusitis with nasal polyps. Thus, our results suggest that LF and OSF-2 gene polymorphisms may have deep impact on the risk of rhinosinusitis nasal polyps' formation which may also depend on asthma or allergy. Our results showed that the 140A/G polymorphism of LF gene and the -33C/G polymorphism of the OSF-2 gene may be associated with the risk of chronic rhinosinusitis with nasal polyps in a Polish population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22173721     DOI: 10.1007/s11033-011-1345-6

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Lactoferrin inhibits the growth of nasal polyp fibroblasts.

Authors:  Beata Nadolska; Marcin Frączek; Tomasz Kręcicki; Maja Kocięba; Michał Zimecki
Journal:  Pharmacol Rep       Date:  2010 Nov-Dec       Impact factor: 3.024

2.  Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues.

Authors:  Russell A Norris; Brook Damon; Vladimir Mironov; Vladimir Kasyanov; Anand Ramamurthi; Ricardo Moreno-Rodriguez; Thomas Trusk; Jay D Potts; Richard L Goodwin; Jeff Davis; Stanley Hoffman; Xuejun Wen; Yukiko Sugi; Christine B Kern; Corey H Mjaatvedt; Debi K Turner; Toru Oka; Simon J Conway; Jeffery D Molkentin; Gabor Forgacs; Roger R Markwald
Journal:  J Cell Biochem       Date:  2007-06-01       Impact factor: 4.429

Review 3.  EPOS Primary Care Guidelines: European Position Paper on the Primary Care Diagnosis and Management of Rhinosinusitis and Nasal Polyps 2007 - a summary.

Authors:  Mike Thomas; Barbara P Yawn; David Price; Valerie Lund; Jocquim Mullol; Wytske Fokkens
Journal:  Prim Care Respir J       Date:  2008-06

4.  Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma.

Authors:  Marian L Kruzel; Attila Bacsi; Barun Choudhury; Sanjiv Sur; Istvan Boldogh
Journal:  Immunology       Date:  2006-06-26       Impact factor: 7.397

Review 5.  Nasal polyposis: an update: editorial review.

Authors:  Ruby Pawankar
Journal:  Curr Opin Allergy Clin Immunol       Date:  2003-02

6.  Normalization of peripheral blood cell composition by lactoferrin in cyclophosphamide-treated mice.

Authors:  Jolanta Artym; Michał Zimecki; Marian Kruzel
Journal:  Med Sci Monit       Date:  2004-03-01

7.  One of two human lactoferrin variants exhibits increased antibacterial and transcriptional activation activities and is associated with localized juvenile periodontitis.

Authors:  Kabilan Velliyagounder; Jeffrey B Kaplan; David Furgang; Diana Legarda; Gill Diamond; Ruth E Parkin; Daniel H Fine
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis.

Authors:  Mark P Rogan; Clifford C Taggart; Catherine M Greene; Philip G Murphy; Shane J O'Neill; Noel G McElvaney
Journal:  J Infect Dis       Date:  2004-08-26       Impact factor: 5.226

9.  Reduced levels of lactoferrin in biofilm-associated chronic rhinosinusitis.

Authors:  Alkis J Psaltis; Peter-John Wormald; Kien R Ha; Lor Wai Tan
Journal:  Laryngoscope       Date:  2008-05       Impact factor: 3.325

10.  The osteogenic transcription factor Runx2 regulates components of the fibroblast growth factor/proteoglycan signaling axis in osteoblasts.

Authors:  Nadiya M Teplyuk; Larisa M Haupt; Ling Ling; Christian Dombrowski; Foong Kin Mun; Saminathan S Nathan; Jane B Lian; Janet L Stein; Gary S Stein; Simon M Cool; Andre J van Wijnen
Journal:  J Cell Biochem       Date:  2009-05-01       Impact factor: 4.429

View more
  4 in total

Review 1.  Genetics of chronic rhinosinusitis: state of the field and directions forward.

Authors:  Joy Hsu; Pedro C Avila; Robert C Kern; M Geoffrey Hayes; Robert P Schleimer; Jayant M Pinto
Journal:  J Allergy Clin Immunol       Date:  2013-04       Impact factor: 10.793

Review 2.  Risk factors for chronic rhinosinusitis.

Authors:  Jin-Young Min; Bruce K Tan
Journal:  Curr Opin Allergy Clin Immunol       Date:  2015-02

3.  A family-based genome-wide association study of chronic rhinosinusitis with nasal polyps implicates several genes in the disease pathogenesis.

Authors:  Anton Bohman; Julius Juodakis; Martin Oscarsson; Jonas Bacelis; Mats Bende; Åsa Torinsson Naluai
Journal:  PLoS One       Date:  2017-12-18       Impact factor: 3.240

Review 4.  Polymorphisms in chronic rhinosinusitis with nasal polyps - a systematic review.

Authors:  Vanessa Ramos Pires Dinarte; Anemari Ramos Dinarte Dos Santos; Luiza Ferreira de Araújo; Mariah Guieiro Alves Dos Reis; Edwin Tamashiro; Fabiana Cardoso Pereira Valera; Wilson Araújo da Silva Júnior; Wilma Terezinha Anselmo-Lima
Journal:  Braz J Otorhinolaryngol       Date:  2017-03-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.